36.42
36.42 (0%)
As of Feb 14, 2025
Simulations Plus, Inc. [SLP]
Source:
Company Overview
Simulations Plus, Inc. was incorporated in California on July 17, 1996. We are a global leader and premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization.
| Country | United States |
| Headquarters | lancaster, california |
| Phone Number | 661-723-7723 |
| Industry | services |
| CEO | Shawn O’Connor |
| Website | www.simulations-plus.com. |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $22.4 |
| Operating Profit | $2.7 |
| Net Income | $3.1 |
| Net Cash | $0.7 |
Profit Ratios
| Gross Margin | $13.1 |
| Operating Margin | 12.1 |
| Profit as % of Revenues | 427% |
| Profit as % of Assets | 1.5% |
| Profit as % of Stockholder Equity | 1.6% |
Management Effectiveness
| Return on Equity | 1.6% |
| Return on Assets | 1.5% |
| Turnover Ratio | 11.3% |
| EBITA | $2.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $201.4 |
| Total Liabilities | $11.9 |
| Operating Cash Flow | $4.4 |
| Investing Cash Flow | $-2.5 |
| Financing Cash Flow | $-1.3 |
